Terms ending in 2036
Every in-force patent on Ono Pharmaceutical Co., Ltd.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,077,247 | Tricyclic Spiro Compound In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,538,502 | Tricyclic Spiro Compound In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,065,226 | Combination Comprising EP4 Antagonist and Immune Checkpoint Inhibitor In force · Medium confidence | Ono Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US 12,497,377 | Tricyclic Spiro Compound In force · Medium confidence | Ono Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US 11,192,876 | Tricyclic Spiro Compound In force · Medium confidence | Ono Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US 12,186,392 | Combination Therapy of an Anti CD20 Antibody with a BTK Inhibitor In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,471,436 | Dihydronaphthalene Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,239,879 | Process for Producing Purinone Derivative In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 10,377,759 | BRK Inhibitory Compound In force · High confidence | Ono Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,215,607 | Biomarker for Diagnosis of Irritable Bowel Syndrome In force · High confidence | Tohoku University | In force | High confidence | |
| 2 more term ends in 2036 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
10 of these are in force and held by Ono Pharmaceutical Co., Ltd..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.